Clinical trial focusing on bone marrow transplantation and rental transplant for multiple myeloma. Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Clinical trial focusing on ACY-1215, bortezomib, and dexamethasone. Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
Clinical trial focusing on cell surface markers and pim kinases. Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Clinical trial focusing on genetics and multiple myeloma. Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile (CoMMpass)
Clinical trial focusing on TH-302, Dexamethasone, and Bortezomib. Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Clinical Trial: Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (ELOQUENT – 2) Sponsor and Collaborators Bristol-Myers Squibb Abbott BiotherapeuticsContinue Reading ClinicalTrials.gov Identifier NCT01239797
Clinical Trial: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT – 1) Sponsor and Collaborators Bristol-Myers SquibbAbbott Biotherapeutics ClinicalTrials.gov IdentifierContinue Reading NCT01335399
A look at the following clinical trial: Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
A look at the following clinical trial: GDC-0449 in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma Who Received an Autologous Stem Cell Transplant
A look at the following clinical trial: Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
Please login or register first to view this content.
